Andreas Bosshard of Mepha-Teva in Switzerland describes Switzerland’s unique generics market, the quality of the Mepha-Teva brand, innovations within generics, and the company’s growth strategy within the Swiss market.
It has been five years since the merger of Teva and Mepha in Switzerland, and curiously the brand name Mepha remains in the Swiss activities. What is the rationale behind this?
The merged companies balance the spirit of the local brand with the strengths of an international company
